16
Dec
Dec
The Vancouver-based drug development company is investigating the use of DMT as a possible treatment for stroke. Psychedelic N,N-Dimethyltryptamine (DMT) has the potential to increase neuron growth by up to 40%, according to new preclinical research by Canadian drug development company Algernon Pharmaceuticals. The study showed that the company’s DMT derivative AP-188 increased the growth […]